1 |
Rosenthal DT, Zhang J, Bao L, et al (2012). RhoC impacts the metastatic potential and abundance of breast cancer stem cells. PLoS One, 7, e40979.
DOI
|
2 |
Huang D, Gao Q, Guo L, et al (2009). Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells, 18, 465-73.
DOI
ScienceOn
|
3 |
Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005). Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell, 121, 465-77.
DOI
ScienceOn
|
4 |
Hu T, Liu S, Breiter DR, et al (2008). Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res, 68, 6533-40.
DOI
ScienceOn
|
5 |
Huang CP, Tsai MF, Chang TH, et al (2013). ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett, 328, 144-51.
DOI
ScienceOn
|
6 |
ICMR (2002). National cancer registry programme, 1981-2001, an overview. Indian council of medical research, New Delhi.
|
7 |
Ilett EJ, Prestwich RJ, Melcher AA (2010).The evolving role of dendritic cells in cancer therapy. Expert Opin Biol Ther, 10, 369.
DOI
ScienceOn
|
8 |
Islam M, Sharma S, Teknos TN (2014). RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3. PLoS One, 9, e88527.
DOI
ScienceOn
|
9 |
Jones T, Ulbright T, Eble J, Baldridge L, Cheng L (2004). OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol, 28, 935-40.
DOI
ScienceOn
|
10 |
Katona TM, Billings SD, Montironi R, Lopez-Beltran A, Cheng L (2007). Expression of OCT4 transcription factor in cutaneous neoplasia. Appl Immunohistochem Mol Morphol, 15, 359-62.
DOI
ScienceOn
|
11 |
Kim MC, Cui FJ, Kim Y (2013). Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells. Asian Pac J Cancer Prev, 14, 3625-30.
과학기술학회마을
DOI
ScienceOn
|
12 |
Cheng L, Sung MT, Cossu-Rocca P, et al (2007). OCT4:biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol, 211, 1-9.
DOI
ScienceOn
|
13 |
Campbell NP, Villaflor VM (2010). Neoadjuvant treatment of esophageal cancer. World J Gastroenterol, 16, 3793-803.
DOI
|
14 |
Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H (2006). POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells, 24, 2685-91.
DOI
ScienceOn
|
15 |
Chen Z, Xu WR, Qian H, et al (2009). Oct4, a novel marker for human gastric cancer. J Surg Oncol, 99, 414-9.
DOI
ScienceOn
|
16 |
Enzinger PC, Mayer RJ (2003). Esophageal cancer. N Engl J Med, 349, 2241-52.
DOI
ScienceOn
|
17 |
Forte A, Schettino MT, Finicelli M, et al (2009). Expression pattern of stemness-related genes in human endometrial and endometriotic tissue. Mol Med, 15, 392-401.
|
18 |
Gao JX (2008). Cancer stem cells: the lessons from precancerous stem cells. J Cell Mol Med, 12, 67-96.
|
19 |
Ghisolfi L, Keates AC, Hu X, Lee D-k, Li CJ (2012). Ionizing radiation induces stemness in cancer cells. PLoS, 7, 43628.
DOI
|
20 |
He W, Li K, Wang F, Qin YR, Fan QX (2012). Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol, 18, 712-9.
DOI
ScienceOn
|
21 |
He W, Li K, Wang F, Qin YR, Fan QX (2012). Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol, 18, 712-9.
DOI
ScienceOn
|
22 |
Hochedlinger K, Plath K (2009). Epigenetic reprogramming and induced pluripotency. Development, 136, 509.
DOI
ScienceOn
|
23 |
Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR (2006). OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer, 120, 1598-602.
|
24 |
Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW (2008). OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cell, 26, 3068-74.
DOI
ScienceOn
|
25 |
Bahl K, Saraya A, Sharma R (2012). Increased levels of circulating and tissue mRNAs of Oct-4, sox-2, Bmi-1 and nanog is escc patients: potential tool for minimally invasive cancer diagnosis. Biomarker Insights, 7, 27-37.
|
26 |
Huang CP, Tsai MF, Chang TH, et al (2013). ALDH positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett, 328, 144-51.
DOI
ScienceOn
|
27 |
Zhou H, Ding S (2010). Evolution of induced pluripotent stem cell technology. Curr Opin Hematol, 17, 276.
DOI
ScienceOn
|
28 |
Zhang X, Komaki R, Wang L, Fang B, Chang JY (2008). Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res, 14, 2813-23.
DOI
ScienceOn
|
29 |
Zhou GX, Li XY, Zhang Q, et al (2013). Effects of the hippo signaling pathway in human gastric cancer. Asian Pac J Cancer Prev, 14, 5199-205.
과학기술학회마을
DOI
ScienceOn
|
30 |
Wang QI, Hei W, Lu C, et al (2009). Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma. Anticancer Res, 29, 1233-42.
|
31 |
Sanada Y, Yoshida K, Ohara M, et al (2006). Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas, 32, 164-70.
DOI
ScienceOn
|
32 |
Tai MH, Chang CC, Olson KL, Trosko JE (2005). Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis, 26, 495-502.
|
33 |
Warren L, Manos PD, Ahfeldt T, et al (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618.
DOI
ScienceOn
|
34 |
Warthemann R, Eildermann K, Debowski K, Behr R (2012). False-positive antibody signals for the pluripotency factor OCT4A (POU5F1) in testis-derived cells may lead to erroneous data and misinterpretations. Mol Hum Reprod, 18, 605-12.
DOI
|
35 |
Wicha MS (2014). Targeting self-renewal, an Achilles’ heel of cancer stem cells. Nat Med, 20, 14-5.
DOI
ScienceOn
|
36 |
Xi Z, Guang-Rong H, Pin H (2011). Over-expression of Oct4 in human esophageal squamous cell carcinoma. Mol Cells, 32, 39-45.
DOI
ScienceOn
|
37 |
Lee J, Kim HK, Rho JY, Han YM, Kim J (2006). The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem, 281, 33554-65.
DOI
ScienceOn
|
38 |
Zangrossi S, Marabese M, Broggini M, et al (2007). Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells, 25, 1675-80.
DOI
ScienceOn
|
39 |
Li X, Wang J, Xu Z, et al (2012). Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci, 13, 7663-75.
DOI
|
40 |
Koukourakis MI, Giatromanolaki A, Tsakmaki V, Danielidis V, Sivridis E (2012). Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer, 106, 846-53.
DOI
ScienceOn
|
41 |
Li MH, Li P, Li PJ (1980). Recent progress in research on esophageal cancer in China. Adv Cancer Res, 33,173-249.
DOI
|
42 |
Matthai C, Horvat R, Noe M, et al (2006). Oct-4 expression in human endometrium. Mol Hum Reprod, 12, 7-10.
DOI
ScienceOn
|
43 |
Monk M, Holding C (2001). Human embryonic genes reexpressed in cancer cells. Oncogene, 20, 8085-91.
DOI
ScienceOn
|
44 |
Nichols J, Zevnik B, Anastassiadis K, et al (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell1, 95, 379-91.
DOI
ScienceOn
|
45 |
Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimates of the world cancer burden: globocan 2000. Int J Cancer, 94, 153-6.
DOI
ScienceOn
|
46 |
Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
DOI
ScienceOn
|
47 |
Niwa H, Miyazaki J, Smith AG (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or selfrenewal of ES cells. Nat Genet, 24, 372-6.
DOI
ScienceOn
|
48 |
Zhang AM, Fan Y, Yao Q, et al (2012). Identification of a cancer stem-like population in the Lewis lung cancer cell line. Asian Pac J Cancer Prev, 13, 761-6.
과학기술학회마을
DOI
ScienceOn
|